An L- and T-type calcium channel inhibitor and mAChR antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Otilonium (bromide)

Item No. 29907

Technical Information
Formal Name
N,N-diethyl-N-methyl-2-[[4-[[2-(octyloxy)benzoyl]amino]benzoyl]oxy]-ethanaminium, monobromide
CAS Number
26095-59-0
Synonyms
  • Octylonium
Molecular Formula
C29H43N2O4 • Br
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mlDMSO: 25 mg/mlEthanol: 10 mg/mlPBS (pH 7.2): 10 mg/ml
λmax
292 nm
SMILES
O=C(NC1=CC=C(C(OCC[N+](CC)(C)CC)=O)C=C1)C2=CC=CC=C2OCCCCCCCC.[Br-]
InChi Code
InChI=1S/C29H42N2O4.BrH/c1-5-8-9-10-11-14-22-34-27-16-13-12-15-26(27)28(32)30-25-19-17-24(18-20-25)29(33)35-23-21-31(4,6-2)7-3;/h12-13,15-20H,5-11,14,21-23H2,1-4H3;1H
InChi Key
VWZPIJGXYWHBOW-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Product Description

    Otilonium is an inhibitor of L-type (IC50 = 2.3 µM) and T-type calcium channels (IC50s = 0.8, 1.1, and 0.4 µM for Cav3.1, Cav3.2, and Cav3.3, respectively).1,2 It is also an antagonist of muscarinic acetylcholine receptors (mAChRs; IC50s = 0.054, 0.4, 0.222, and 0.156 µM for M1, M2, M4, and M5 muscarinic receptors, respectively) and the platelet activating factor (PAF) receptor (IC50 = 0.0552 µM).3 Otilonium inhibits the inward calcium current in isolated rat colonic smooth muscle cells (EC50 = 885 nM), an effect that can be blocked by the L-type calcium channel inhibitor nifedipine (Item No. 11106).1 It inhibits contractions induced by the muscarinic acetylcholine receptor (mAChR) agonist methacholine in isolated circular muscle of the guinea pig proximal colon (IC50 = 3.7 µM).4 Otilonium (4 mg/kg) decreases fecal excretion and wet dog shakes and increases the tail withdrawal latency in the tail-flick test in a rat model of opioid withdrawal syndrome induced by morphine and naloxone.5

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Martin, M.T., Hove-Madsen, L., and Jimenez, M. Otilonium bromide inhibits muscle contractions via L-type calcium channels in the rat colon. Neurogastroenterol. Motil. 16(2), 175-183 (2004).

    2. Strege, P.R., Sha, L., Beyder, A., et alT-type Ca2+ Channel Modulation by Otilonium Bromide. Am. J. Physiol. Gastrointest. Liver Physiol. 298(5), G706-G713 (2010).

    3. Evangelista, S., Giachetti, A., Chapelain, B., et alReceptor binding profile of otilonium bromide. Pharmacol. Res. 38(2), 111-117 (1998).

    4. Santicioli, P., Zagorodnyuk, V., Renzetti, A.R., et alAntimuscarinic, calcium channel blocker and tachykinin NK2 receptor antagonist actions of otilonium bromide in the circular muscle of guinea-pig colon. Naunyn-Schmiedebergs Arch. Pharmacol. 359(5), 420-427 (1999).

    5. Pinelli, A., Trivulzio, S., and Vignati, S. Effects exerted by otilonium bromide administration on precipitated opioid withdrawal syndrome in rats. Toxicology 122(1-2), 23-37 (1997).